他剪短
发表于 2025-3-21 19:53:41
书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0281033<br><br> <br><br>书目名称Discovering and Developing Molecules with Optimal Drug-Like Properties读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0281033<br><br> <br><br>
Conducive
发表于 2025-3-21 21:03:44
http://reply.papertrans.cn/29/2811/281033/281033_2.png
表被动
发表于 2025-3-22 02:24:14
Enabling Discovery Through Leveraging and Miniaturizing Pharmaceutical Principles and Processesneed to execute in a parallel fashion. These realities in turn can place severe restrictions on the options available to the development and implementation of drug delivery strategies. While one would expect the contrary, these realities do not preclude the use of development-stage formulation techn
的阐明
发表于 2025-3-22 08:13:21
Diagnosing Biopharmaceutical Limitationsands adequate exposure throughout the dosing interval and none of the compounds tested approaches the targeted exposure. Studying compounds to determine why exposure is poor may assist the structure–activity relationship (SAR) process, even if the compounds are not suitable for further development.
空气
发表于 2025-3-22 12:23:39
http://reply.papertrans.cn/29/2811/281033/281033_5.png
腐蚀
发表于 2025-3-22 16:38:07
http://reply.papertrans.cn/29/2811/281033/281033_6.png
腐蚀
发表于 2025-3-22 18:55:35
http://reply.papertrans.cn/29/2811/281033/281033_7.png
狂热文化
发表于 2025-3-22 23:23:43
http://reply.papertrans.cn/29/2811/281033/281033_8.png
Platelet
发表于 2025-3-23 01:26:02
http://reply.papertrans.cn/29/2811/281033/281033_9.png
轻触
发表于 2025-3-23 07:39:44
Practical Considerations for Spray Dried Formulation and Process Developmentug to a high energy polymer stabilized amorphous state. Spray drying is a mature process with demonstrated production capability from lab to commercial scale for manufacturing amorphous solid dispersions. However, the impact of the drying process on the performance, manufacture, and stability of the